As Head of Innovation, my main mission is to support the research & innovation approach within the company, by optimizing the processes/exchanges between the departments and by rationalizing the strategy in order to bring out in the best conditions the upcoming innovations that will drive SynapCell's growth forward.

National business mentoring service provider in New Zealand. The service matches experienced businesspeople, the Mentors, with business owners.The Mentee, is looking to learn from those who have the experience and knowledge to empower them to be better and to navigate the inevitable challenges they face in today’s competitive business environment.

SINNOVIAL is a Medtech company which develops personalized medicine tools in the treatment of inflammatory diseases (www.sinnovial.com).Goals: improve the patient’s daily life and save time on disease's progressionVision: generalize the predictive approach in Rheumatology by using a companion-test before any treatment's prescription (focused therapy, companion-diagnostic, personalized medicine)Missions: management, strategy/roadmap, partnerships, financeKey achievements:- CE certification for Medical Device (ISO 13485 & 14971)- Software development (ISO 62304, 62366)- European multicentric Phase 3 clinical trial- Funding (banks, grants ≥ € 2M)- Pharmaceutical, Insurance companies’ partnerships (≥ €850k)- EIT Health Innovation by Idea (winner 2019 - € 750k)- Investors Forum 5i “most Innovative Project” (winner 2017)- PERMIDES European Cluster Platform (winner 2016) - French Ministry of Research Awards (winner 2015)

Medical Device, Prescription Assistance Software, IoT, etc.

Biofeedback in Strength and Skill Training medtech device BiSSkApp.Innovative technologies that enable increased and equitable access to rehabilitation, benefitting patients through improved health outcomes, quality of life and community integration, and community through reduced healthcare costs.Missions: strategy, planning/roadmap, budget, reportingKey achievements:- Functional medical device prototype & User Interface (IoT)- Roadmap, Scoping phase & validation of technical partners- Minister of Business Innovation Awards (Nov. 20 - NZ$ 250k)- HealthTech Supernode Challenge (Winner, Oct. 2020)

MELLITECH SAS is a biotechnology start-up based on a technology spun out of the Commissariat à l'Energie Atomique & Université Joseph Fourrier, focused on the discovery & development of innovative therapies and diagnostics for the treatment of type 1 and type 2 diabetes.Missions: operations management, strategy/innovation, partnerships, financeKey achievements: - Technology transfer contract (J&J subsidiary)- Fundraising, French Ministry of Research (winner 2006 - € 1.3M)

Intitial creation – business plan, recruitment of co-founders and technical staff, laboratory investment, start-up funds and institutional grants; management of strategic priorities, HR, suppliers & scientific service providers, cashflow, relationships with investors (Business Angels) and with sources of grants / awards / government loans, taxes and legal.

Administrative & Financial: intitial creation – business plan, start-up funds and institutional grants, cashflow, loans, taxes and legal.Production: management of the supply chain and industrial partners.